FDA Says Its Safety Review of Abortion Pill Will Continue Into Next Year
(MedPage Today) -- The FDA says its ongoing safety review of mifepristone, the nation's main abortion pill, will continue into next year, a timeline that was quickly condemned by abortion opponents hoping to see the drug's use curtailed. The FDA...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Sources: winnipegfreepress.com · medpagetoday.com · statnews.com
This story
This is one outlet's version. Read the fullest account.
- FDA says its safety review of abortion pill will continue into next year statnews.com
- FDA says its safety review of abortion pill will continue into next year winnipegfreepress.com